HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

Current stock price

33.3 EUR
-0.5 (-1.48%)
Last:

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • ALHEX had positive earnings in the past year.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • Of the past 5 years ALHEX 4 years were profitable.
  • In the past 5 years ALHEX always reported a positive cash flow from operatings.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.46%, ALHEX is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • ALHEX's Return On Equity of 3.94% is in line compared to the rest of the industry. ALHEX outperforms 54.29% of its industry peers.
  • ALHEX's Return On Invested Capital of 3.70% is in line compared to the rest of the industry. ALHEX outperforms 42.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALHEX is in line with the industry average of 9.43%.
  • The 3 year average ROIC (8.77%) for ALHEX is well above the current ROIC(3.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 48.57% of the companies in the same industry.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • ALHEX has a Operating Margin of 2.30%. This is comparable to the rest of the industry: ALHEX outperforms 42.86% of its industry peers.
  • In the last couple of years the Operating Margin of ALHEX has declined.
  • Looking at the Gross Margin, with a value of 21.14%, ALHEX is doing worse than 74.29% of the companies in the same industry.
  • ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
  • ALHEX has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.13. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ALHEX (2.13) is comparable to the rest of the industry.
  • ALHEX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • ALHEX has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACC0.53
WACC6.98%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ALHEX has a Current Ratio of 1.31. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHEX's Current ratio of 1.31 is in line compared to the rest of the industry. ALHEX outperforms 42.86% of its industry peers.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.99, ALHEX is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • ALHEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.84%.
  • Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
  • The Revenue for ALHEX has decreased by -30.53% in the past year. This is quite bad
  • Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • ALHEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.47% yearly.
  • The Revenue is expected to grow by 3.02% on average over the next years.
EPS Next Y4.15%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.42 indicates a quite expensive valuation of ALHEX.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALHEX is on the same level as its industry peers.
  • ALHEX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.66.
  • With a Price/Forward Earnings ratio of 8.58, the valuation of ALHEX can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 65.71% of the companies listed in the same industry.
  • ALHEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.00.
Industry RankSector Rank
PE 25.42
Fwd PE 8.58
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ALHEX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.18
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHEX does not grow enough to justify the current Price/Earnings ratio.
  • ALHEX's earnings are expected to grow with 36.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.13
PEG (5Y)N/A
EPS Next 2Y35.61%
EPS Next 3Y36.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.38%, ALHEX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.92, ALHEX has a dividend in line with its industry peers.
  • ALHEX's Dividend Yield is a higher than the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 2026 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (4/21/2026, 7:00:00 PM)

33.3

-0.5 (-1.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners15.62%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap231.10M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86
Price Target46.67 (40.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.55%
PT rev (3m)0.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.67%
EPS NY rev (3m)18.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.42
Fwd PE 8.58
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 2.28
EV/EBITDA 6.18
EPS(TTM)1.31
EY3.93%
EPS(NY)3.88
Fwd EY11.66%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)6.13
PEG (5Y)N/A
Graham Number31.2014 (-6.3%)
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.13
F-Score4
WACC6.98%
ROIC/WACC0.53
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y4.15%
EPS Next 2Y35.61%
EPS Next 3Y36.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year80.1%
EBIT Next 3Y49.28%
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA Fundamental Analysis FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHEX.PA.


Can you provide the valuation status for HEXAOM?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for HEXAOM?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALHEX stock?

The Earnings per Share (EPS) of HEXAOM (ALHEX.PA) is expected to grow by 4.15% in the next year.


How sustainable is the dividend of HEXAOM (ALHEX.PA) stock?

The dividend rating of HEXAOM (ALHEX.PA) is 3 / 10 and the dividend payout ratio is 0%.